抗血栓药物对胰切除术后出血的影响:回顾性多中心研究
这项回顾性多中心研究分析了2007至2016年间两个外科中心的1,297例胰切除术患者,评估术前使用抗血栓药物(ATA)与胰切除术后出血(PPH)的关联。结果显示ATA组PPH发生率显著高于对照组(8.3% vs 2.0%,p<0.001),ATA使用是PPH的独立危险因素(OR 3.58,95%CI 1.29-9.91,p=0.014)。联合抗血栓治疗患者PPH Grade C风险显著,且ATA组迟发性出血中位发生时间晚于对照组(17.5 vs 8.5天,p=0.032)。
要点
- 术前使用ATA是PPH的独立危险因素,OR为3.58。
- 联合抗血栓治疗患者PPH Grade C风险显著。
- ATA组迟发性出血发生时间更晚,中位17.5天。
核心结论
- ATA使用史是PPH的显著危险因素,术后恢复ATA可能与PPH风险增加相关。
- 接受联合抗血栓治疗的患者可能面临特别高的PPH风险。
研究设计与样本
- 回顾性多中心研究,纳入2007至2016年间两个外科中心的1,297例胰切除术患者。
- ATA组包括术前服用阿司匹林、氯吡格雷、噻氯匹定、华法林、直接口服抗凝药和静脉普通肝素的患者,共144例;对照组1,153例。
主要发现
- 共35例患者发生PPH,ATA组PPH发生率8.3%,对照组2.0%,p<0.001。
- 多因素分析显示ATA使用是PPH的独立不良危险因素(OR 3.58,95%CI 1.29-9.91,p=0.014)。
- 按术前ATA治疗分层,联合抗血栓治疗患者PPH Grade C风险显著。
- ATA组迟发性出血(术后>24小时)中位发生时间晚于对照组(17.5 vs 8.5天,p=0.032),术后恢复ATA的患者发生率有升高趋势。
关键数值与推荐
- ATA组PPH发生率8.3%(对象为术前使用ATA的胰切除术患者),对照组2.0%,p<0.001。
- ATA使用对PPH的OR为3.58(95%CI 1.29-9.91,p=0.014)。
- 迟发性出血中位发生时间:ATA组17.5天,对照组8.5天,p=0.032。
临床怎么用
- 术前应详细评估患者ATA使用史,识别PPH高危人群。
- 对接受联合抗血栓治疗的患者,围术期应加强PPH监测与防范。
- 术后恢复ATA需权衡出血风险,尤其关注迟发性出血可能。
局限性
- 回顾性研究设计可能存在选择偏倚和混杂因素。
- 样本来自两个外科中心,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This retrospective multicenter study aimed to evaluate the risk of postpancreatectomy hemorrhage (PPH) in patients receiving antithrombotic agents (ATAs). PPH is the most severe complication after pancreatectomy. However, there is little known about the strength of the association between ATA use, PPH, and other clinical outcomes. STUDY DESIGN: Between 2007 and 2016, 1,297 patients underwent pancreatectomy at 2 surgical centers. ATA use included aspirin, clopidogrel, ticlopidine, warfarin, direct oral anticoagulants, and intravenous unfractionated heparin. The ATA group was composed of 144 patients who were taking ATAs before surgery. RESULTS: A total of 35 patients developed PPH. The patients in the ATA group showed higher frequency (8.3% vs 2.0%, p < 0.001) of PPH compared with the control group (n = 1,153). In multivariate analysis, ATA use was an independent adverse risk factor for PPH (odds ratio [OR] 3.58, 95% CI 1.29-9.91, p = 0.014). Stratification by preoperative ATA therapy revealed a significant risk of PPH Grade C in patients receiving combined AT therapy. The median onset of late hemorrhage (>24 hours post-surgery) in the ATA group was later than in the control group (17.5 vs 8.5 days, p = 0.032), and the incidence tended to be higher in patients who restarted ATAs postoperatively. CONCLUSIONS: History of ATA use is a significant risk factor for PPH, and postoperative resumption of ATAs appears to be associated with an increased risk of PPH. Patients receiving combined antithrombotic therapy may be at particularly high risk for PPH.
引用
- Nakamura K, Sho M, Satoi S, et al. Impact of Antithrombotic Agents on Postpancreatectomy Hemorrhage: Results from a Retrospective Multicenter Study. J Am Coll Surg. 2020. PMID: 32634474. doi:10.1016/j.jamcollsurg.2020.06.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。